PENTOXIL Drug Patent Profile
When do Pentoxil patents expire, and what generic alternatives are available?
Pentoxil is a drug marketed by Upsher Smith Labs and is included in one NDA.
The generic ingredient in PENTOXIL is pentoxifylline. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pentoxil
A generic version of PENTOXIL was approved as pentoxifylline by RISING on July 8th, 1997.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PENTOXIL?
- What are the global sales for PENTOXIL?
- What is Average Wholesale Price for PENTOXIL?
Summary for PENTOXIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 81 |
| Clinical Trials: | 2 |
| Patent Applications: | 4,512 |
| DailyMed Link: | PENTOXIL at DailyMed |
Recent Clinical Trials for PENTOXIL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Mayo Clinic | Phase 3 |
| Indiana University | Phase 2 |
US Patents and Regulatory Information for PENTOXIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | PENTOXIL | pentoxifylline | TABLET, EXTENDED RELEASE;ORAL | 074962-001 | Mar 31, 1999 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
